AYTU BIOPHARMA, INC Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
AYTU BIOPHARMA, INC (AYTU) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $625.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-09-22
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2026 was $625.00K, a 23.87% decline from fiscal 2025.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $821.00K, a 2180.56% increase from fiscal 2024.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $36.00K, a 69.23% decline from fiscal 2023.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $117.00K, a 138.78% increase from fiscal 2022.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2026-06-30 | $625.00K 10-K · filed 2026-09-22 | |
| 2025-06-30 | $821.00K 10-K · filed 2026-09-22 | |
| 2024-06-30 | $36.00K 10-K · filed 2025-09-23 | $37.00K 10-K · filed 2024-09-26 |
| 2023-06-30 | $117.00K 10-K · filed 2024-09-26 | |
| 2022-06-30 | $49.00K 10-K · filed 2023-10-12 | |
| 2021-06-30 | $651.00K 10-K · filed 2022-09-27 | |
| 2020-06-30 | $50.00K 10-K · filed 2021-09-28 | |
| 2019-06-30 | $192.00K 10-K · filed 2020-10-06 | |
| 2018-06-30 | $101.00K 10-K · filed 2019-09-26 | |
| 2017-06-30 | $100.00K 10-K · filed 2018-09-06 | |
| 2016-06-30 | $6.00K 10-K · filed 2017-08-31 | $5.86K 10-K · filed 2016-09-01 |
| 2015-06-30 | $2.11K 10-K · filed 2016-09-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |